Dr. Richard Isaacson joined Bloomberg’s Longevity with David Rubenstein to discuss the neuroscience of aging, memory loss, and the latest advances in Alzheimer’s prevention. During the interview, Dr. Isaacson shared how precision medicine, blood biomarkers, and personalized prevention strategies are changing the way clinicians identify Alzheimer’s risk and help patients protect their brain health before symptoms develop.

Highlighting the importance of early detection, Dr. Isaacson explained:

“There are 47 million Americans living with the pathology of Alzheimer’s silently starting in their brain, often decades before symptoms.”

Watch the full episode of Bloomberg’s Longevity with David Rubenstein to hear Dr. Isaacson discuss the future of Alzheimer’s prevention and the science behind maintaining lifelong cognitive health.